Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002414877 | SCV002722191 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-09-19 | criteria provided, single submitter | clinical testing | The p.C620Y variant (also known as c.1859G>A), located in coding exon 11 of the ATM gene, results from a G to A substitution at nucleotide position 1859. The cysteine at codon 620 is replaced by tyrosine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV003229091 | SCV003926353 | uncertain significance | not provided | 2022-11-18 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Baylor Genetics | RCV003465744 | SCV004211965 | uncertain significance | Familial cancer of breast | 2023-05-12 | criteria provided, single submitter | clinical testing |